H. Lundbeck A/S (HLBBF)
6.64
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
H. Lundbeck Price : 6.64 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 0.000 |
| Aug 24, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 0.000 |
| Aug 21, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 0.000 |
| Aug 20, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 0.000 |
| Aug 19, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 0.000 |
| Aug 18, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 0.000 |
| Aug 17, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 0.000 |
| Aug 14, 2026 | 6.64 | 6.64 | 6.64 | 6.64 | 600.00 |
| Aug 13, 2026 | 6.05 | 6.05 | 6.05 | 6.05 | 0.000 |
| Aug 12, 2026 | 6.05 | 6.05 | 6.05 | 6.05 | 0.000 |
| Aug 11, 2026 | 6.05 | 6.05 | 6.05 | 6.05 | 726.00 |
| Aug 10, 2026 | 6.43 | 6.43 | 6.43 | 6.43 | 0.000 |
| Aug 07, 2026 | 6.43 | 6.43 | 6.43 | 6.43 | 0.000 |
| Aug 06, 2026 | 6.43 | 6.43 | 6.43 | 6.43 | 0.000 |
| Aug 05, 2026 | 6.43 | 6.43 | 6.43 | 6.43 | 800.00 |
| Aug 04, 2026 | 6.95 | 6.95 | 6.95 | 6.95 | 0.000 |
| Aug 03, 2026 | 6.95 | 6.95 | 6.95 | 6.95 | 0.000 |
| Jul 31, 2026 | 6.95 | 6.95 | 6.95 | 6.95 | 0.000 |
| Jul 30, 2026 | 6.95 | 6.95 | 6.95 | 6.95 | 100.00 |
| Jul 29, 2026 | 6.207 | 6.207 | 6.207 | 6.207 | 0.000 |
| Jul 28, 2026 | 6.207 | 6.207 | 6.207 | 6.207 | 0.000 |
| Jul 27, 2026 | 6.207 | 6.207 | 6.207 | 6.207 | 424.00 |
| Jul 24, 2026 | 6.60 | 6.60 | 6.60 | 6.60 | 0.000 |
| Jul 23, 2026 | 6.60 | 6.60 | 6.60 | 6.60 | 0.000 |
| Jul 22, 2026 | 6.60 | 6.60 | 6.60 | 6.60 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 48.66 |
| ALK-Abello A/S | 37.92 |
| AstraZeneca PLC | 169.66 |
| ANI Pharmaceuticals, Inc. | 75.65 |
| Corcept Therapeutics, Inc. | 123.57 |
Price Related Metrics
| PE Ratio | 10.86 |
| PS Ratio | 1.644 |
| PEG Ratio | 0.5114 |
| Price to Book Value | 1.603 |
| Price to Free Cash Flow | 9.148 |
| Earnings Yield | 9.21% |
| Market Cap | 6.588B |
| PEGY Ratio | 0.4526 |
| Operating PE Ratio | 6.036 |
| Normalized PE Ratio | 9.169 |